Cervarix™: a vaccine for the prevention of HPV 16, 18-associated cervical cancer
Archana Monie1, Chien-Fu Hung1,2, Richard Roden1,2,4, T-C Wu1,2,3,41Departments of Pathology, 2Obstetrics and Gynecology, 3Molecular Microbiology and Immunology, and 4Oncology, 5Institute of Genetic Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland, USAAbstract: Cervical cancer conti...
Guardado en:
Autores principales: | Archana Monie, Chien-Fu Hung, Richard Roden, T-C Wu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/50025eee55f54ce89959a6bc8ee34d45 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody
por: Shiwen Peng, et al.
Publicado: (2021) -
CERVICAL NEOPLASIA AND VIRUS LOAD OF HPV 16 GENOTYPE
por: V. S. Chirsky, et al.
Publicado: (2014) -
TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer
por: Ikumi Kuno, et al.
Publicado: (2021) -
The aqueous extract of Ficus religiosa induces cell cycle arrest in human cervical cancer cell lines SiHa (HPV-16 Positive) and apoptosis in HeLa (HPV-18 positive).
por: Amit S Choudhari, et al.
Publicado: (2013) -
Blockade of Axl signaling ameliorates HPV16E6-mediated tumorigenecity of cervical cancer
por: Eun-Hee Lee, et al.
Publicado: (2017)